Skip to main content
SpringerLink
Log in

Metabolic ratios of four probes of CYP2D6 in Turkish subjects: A cross-over study

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The relationships among the metabolic ratios for the standard probe drugs of CYP2D6 activity, such as debrisoquine, sparteine, metoprolol and dextromethorphan, were studied in 32 Turkish subjects. All subjects were randomly selected according to their phenotypes from a group of 111 Turkish subjects whose oxidation status had been tested for debrisoquine previously. All subjects were given a 10 mg debrisoquine tablet, a 100 mg sparteine tablet, a 100 mg metoprolol tablet and a 20 mg dextromethorphan capsule orally with a wash-out period of at least 1 week between each probe administration. Metabolic ratios were calculated as percentage of dose excreted as parent drug/percentage of dose excreted as its hydroxymetabolite of parent drug in 0–8 h urine. Three poor metabolisers (PM) of debrisoquine were identified. They were also PMs of the other test probes and no misclassification by the 4 phenotyping methods was observed. All six correlations among the metabolic ratios of the 4 probe drugs assessed by Spearman’s rank test were highly significant (P<0.001). The present findings indicate that the oxidative metabolism of debrisoquine, sparteine, metoprolol and dextromethorphan is catalysed by the same cytochrome P450 in the Turkish subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eichelbaum M., Gross A.S. (1990): The genetic polymorphism of debrisoquine sparteine metabolism — clinical aspects. Pharmacol. Ther., 46, 377–394.

    Article  PubMed  CAS  Google Scholar 

  2. Horai Y., Ishizaki T., Taga J., Ishikawa K. (1990): Correlation among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population. Br. J. Clin. Pharmacol., 29, 111–115.

    PubMed  CAS  Google Scholar 

  3. Bozkurt A., Basci N.E., Isimer A., Sayal A., Kayaalp S.O. (1994): Polymorphic debrisoquine metabolism in a Turkish population. Clin. Pharmacol. Ther., 55, 399–401.

    PubMed  CAS  Google Scholar 

  4. Eichelbaum M., Bertilsson L., Sawe J., Zekorn C. (1982): Polymorphic oxidation as sparteine and debrisoquine: related pharmacogenetic entities. Clin. Pharmacol. Ther., 31, 184–186.

    PubMed  CAS  Google Scholar 

  5. McGourthy J.C., Silas J.H., Lennard M.S., Tucker G.T., Woods H.F. (1985): Metoprolol metabolism and debrisoquine oxidation polymorphism-population and family studies. Br. J. Clin. Pharmacol., 20, 555–566.

    Google Scholar 

  6. Basci N.E., Bozkurt A., Isimer A., Kayaalp S.O. (1994): Correlation between the metabolic ratios of debrisoquine and metoprolol in Turkish subjects. Pharmacol. Toxicol., 75, 62–64.

    Article  PubMed  CAS  Google Scholar 

  7. Basci N.E., Brøsen K., Bozkurt A., Isimer A., Sayal A., Kayaalp S.O. (1994): S-mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population. Br. J. Clin. Pharmacol., 38, 463–465.

    PubMed  CAS  Google Scholar 

  8. Woolhouse W.W., Eichelbaum M., Oates N., Idle J.R., Smith R.L. (1985): Dissociation of coregulatory control of debrisoquine/phenformin and sparteine oxidation in Ghanaians. Clin. Pharmacol. Ther., 37, 512–521.

    PubMed  CAS  Google Scholar 

  9. Sommers D.K., Moncrieff J., Avenant J. (1989): Metoprolol alpha-hydroxylation polymorphism in the San Bushmen of Southern Africa. Hum. Toxicol., 8, 39–43.

    Article  PubMed  CAS  Google Scholar 

  10. Iyun A.O., Lennard M.S., Tucker G.T., Woods H.F. (1986): Metoprolol and debrisoquine metabolism in Nigerians: lack of evidence for polymorphic oxidation. Clin. Pharmacol. Ther., 40, 387–394.

    PubMed  CAS  Google Scholar 

  11. Simooya O.O., Njunju E., Hodjegan A.R., Lennard M.S., Tucker G.T. (1993): Debrisoquine and metoprolol oxidation in Zambians: a population study. Pharmacogenetics, 3, 205–208.

    Article  PubMed  CAS  Google Scholar 

  12. Bozkurt A., Basci N.E., Isimer A., Kayaalp S.O. (1993): Determination of debrisoquine and 4-hydroxydebrisoquine in urine by high performance liquid chromatography with fluorescence detection after solid phase extraction. J. Pharm. Biomed. Anal., 11, 745–749.

    Article  PubMed  CAS  Google Scholar 

  13. Evans D.A.P., Harmer D., Downham D.Y., Whirbley E.J., Smith R.L. (1980): Family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J. Med. Genet., 17, 102–105.

    Article  PubMed  CAS  Google Scholar 

  14. Lennard M.S., Silas J.H. (1983): Rapid determination of metoprolol in human plasma and urine by high performance liquid chromatography. J. Chromatogr, 272, 205–209.

    Article  PubMed  CAS  Google Scholar 

  15. Lam Y.W.F., Rodriguez S.Y. (1993): High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection. Ther. Drug Monit., 15, 300–304.

    Article  PubMed  CAS  Google Scholar 

  16. Schmid B., Bircher M.D., Preisig R., Küpfer A. (1985): Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquine hydroxylation. Clin. Pharmacol. Ther., 38, 618–624.

    PubMed  CAS  Google Scholar 

  17. Vinks A., Inaba T., Otton S.V., Kalow W. (1982): Sparteine metabolism in Canadian Caucasians. Clin. Pharmacol. Ther., 31, 23–29.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey

    A. Bozkurt, N. E. Başçi & S. O. Kayaalp

  2. Department of Pharmacology, Faculty of Medicine, Gülhane Military Medical Academy, Ankara, Turkey

    A. Isimer & A. Sayal

Authors
  1. A. Bozkurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. E. Başçi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Isimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Sayal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. O. Kayaalp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bozkurt, A., Başçi, N.E., Isimer, A. et al. Metabolic ratios of four probes of CYP2D6 in Turkish subjects: A cross-over study. European Journal of Drug Metabolism and Pharmacokinetics 21, 309–314 (1996). https://doi.org/10.1007/BF03189732

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189732

Keywords

Search

Navigation